Written by the Nuvirox Research Team
Key points
- Glycation is a non-enzymatic reaction in which sugars stick to proteins and, over months to years, form permanent cross-links called advanced glycation end products (AGEs).
- It matters most in proteins your body almost never replaces — skin collagen, artery walls, the lens of the eye — not in the fast-turnover proteins that get recycled weekly.
- The human trial evidence on dietary AGEs is genuinely mixed: a 17-trial meta-analysis found improvements in insulin resistance and cholesterol, while a well-controlled 24-person trial found nothing at all.
Short answer: glycation is real chemistry with real consequences, but the version sold in supplement marketing is far more certain than the evidence. Sugars in your bloodstream do bond spontaneously to proteins, and over long enough timescales some of those bonds become permanent cross-links that stiffen tissue. That much is settled biochemistry. What remains contested is how much of your AGE burden comes from food versus from your own metabolism, and whether eating fewer AGEs measurably changes anything in a healthy person. The fair reading is that glycation is a legitimate mechanism of aging that has been oversold as a diet problem you can solve with a shopping list.
What is glycation, exactly?
Glycation is what happens when a sugar molecule attaches to a protein without an enzyme telling it to. Your body runs thousands of controlled reactions where enzymes attach sugars to proteins deliberately — that process is called glycosylation, and it is essential. Glycation is the uncontrolled version: a glucose or fructose molecule bumps into a protein, sticks, and nobody supervises what happens next.
The reaction proceeds in stages. First comes a Schiff base, a loose and fully reversible attachment that forms in minutes. If blood sugar drops, it simply comes apart. If the sugar stays, the Schiff base rearranges into a more stable structure called an Amadori product — this is the stage that HbA1c measures, which is why HbA1c reflects roughly three months of average glucose. Over much longer periods, some Amadori products undergo further oxidation and rearrangement into advanced glycation end products, and those are effectively permanent.
The glycation cascade. Each stage is slower and less reversible than the one before it; only the final stage produces the permanent cross-links associated with tissue stiffening.
Why does glycation matter more in some tissues than others?
Because permanence only matters if the protein sticks around. Your body constantly demolishes and rebuilds proteins. Blood albumin turns over in about three weeks. Gut lining cells are replaced in days. If a protein like that gets glycated, the damage is disposed of along with the protein, and the whole question is moot.
The problem is the small set of proteins your body barely replaces. Skin and artery collagen have a half-life measured in years — some estimates put dermal collagen turnover at well over a decade. The crystallin proteins in your eye lens are laid down before birth and essentially never replaced. In those tissues, glycation is cumulative in a way it simply is not elsewhere. Cross-linked collagen loses elasticity, which is one of the mechanisms proposed for arterial stiffening and for the specific quality of aged skin that no moisturizer addresses. It is also the reason glycation shows up so often in conversations about whether collagen supplements do anything for skin.
Glycation is a compounding problem only in tissues with slow protein turnover. This is why the same chemistry produces visible effects in skin and arteries but not in blood or gut lining.
What human studies actually show
The largest pooled analysis found modest metabolic benefits from lowering dietary AGEs. Baye and colleagues pooled 17 randomised controlled trials comprising 560 participants and found that low-AGE diets reduced insulin resistance by a mean difference of 1.3, total cholesterol by 8.5 mg/dL, and LDL by 2.4 mg/dL. Importantly, they found no change in body weight, fasting glucose, two-hour glucose, HbA1c, HDL, or blood pressure. It is a real signal in a narrow band of outcomes, not a broad metabolic overhaul.
A carefully controlled trial in healthy older adults found nothing. This is the counterweight worth sitting with. Semba and colleagues randomised 24 healthy adults aged 50 to 69 to isocaloric, food-equivalent diets prepared at either high or mild temperatures for six weeks. The low-AGE diet did what it was supposed to biochemically — serum carboxymethyl-lysine fell from 763 to 679 ng/mL and urinary CML dropped too. But endothelial function, measured by peripheral arterial tonometry, did not change. Neither did any inflammatory mediator. The chemistry moved; the physiology did not.
A crossover trial in overweight adults also came back flat on cardiovascular outcomes. Twenty participants alternated low- and high-AGE diets for two weeks each with a four-week washout. Systolic blood pressure, diastolic blood pressure, mean arterial pressure, and pulse pressure were all unchanged.
Systematic reviews keep flagging the same structural problem. Clarke and colleagues reviewed 12 dietary AGE interventions totalling 293 participants and noted how small and short the underlying literature is. A 2024 systematic review focused on people with diabetes reached similar conclusions. Nobody has run a trial long enough to test the thing that actually matters, which is whether decades of lower AGE intake changes tissue cross-linking or clinical outcomes.
Study snapshot
| Trial | Semba et al., J Nutr 2014 (NCT01402973) |
| Design | Randomised, parallel-arm, controlled feeding |
| Participants | 24 healthy adults, aged 50–69 |
| Intervention | Isocaloric diets cooked at high vs. mild temperatures, 6 weeks |
| Result | Serum and urinary CML fell on the low-AGE diet; no change in endothelial function or inflammatory markers |
What lowering your AGE intake won't do
It will not reverse existing cross-links. Once an AGE forms in collagen, no dietary change removes it; a class of experimental AGE-breaker compounds was investigated for exactly this and has not produced an approved therapy. It will not reliably change your blood pressure, weight, or HbA1c — the pooled data are explicit on that point. And it will not make you feel different day to day. Glycation operates on a timescale of years, which means it is a poor explanation for how tired you felt this afternoon.
There is also an important distinction that gets lost. Most of the AGEs in your body are generated internally from your own blood sugar, not absorbed from food. How much dietary AGE is even absorbed intact is still debated. If your fasting glucose and HbA1c are drifting upward, that internal production is the larger lever, and it is a conversation to have with a clinician rather than a cooking-method problem. Persistent fatigue, unexplained thirst, blurred vision, or slow-healing wounds are reasons to get bloodwork rather than reasons to change your roasting temperature.
If you want to lower glycation, what actually has support?
The interventions with the best evidence are unglamorous. Keeping average blood glucose in a healthy range reduces the substrate for the entire reaction — this is why HbA1c, itself a glycation product, is the standard measure. Cooking methods do change the AGE content of food substantially: boiling, steaming, poaching, and stewing generate far fewer AGEs than grilling, frying, roasting, and broiling, and that is a low-cost change if you want to make it. Trial durations in this literature run two to eight weeks for biochemical endpoints, so if you are tracking anything, give it at least that long.
Beyond that, the honest position is that glycation sits alongside oxidative stress and the other mechanisms catalogued in the hallmarks of aging framework: well characterised in the lab, hard to move measurably in a living person over a realistic timeframe. If you are curious about your own glucose patterns, it is worth reading first about what continuous glucose monitors can and cannot tell someone without diabetes before buying one.
Frequently asked questions
Does eating sugar directly cause wrinkles?
Not in the direct way the phrase suggests. Sugar raises blood glucose, and higher average glucose over years increases glycation of the long-lived collagen in skin, which contributes to loss of elasticity. But that is a slow, cumulative process operating over decades alongside sun exposure, smoking, and genetics — not a same-week effect from a dessert. Our overview of what the skin research actually supports covers the broader picture.
Can you test your AGE levels?
Partly. Serum and urinary carboxymethyl-lysine can be measured in a research setting, and skin autofluorescence devices estimate tissue AGE accumulation non-invasively. Neither is a routine clinical test, and neither has an established action threshold. HbA1c is the closest thing to a widely available glycation measure, and it reflects roughly the last three months.
Are AGEs in food actually absorbed?
This is genuinely unresolved. Some dietary AGEs are absorbed, but estimates of how much vary widely across studies, and much of what is absorbed appears to be excreted. The Semba trial showed that a low-AGE diet does lower circulating CML, so something is getting through — but that same trial found no downstream physiological effect over six weeks.
Do antioxidant supplements block glycation?
There is laboratory evidence that various compounds inhibit AGE formation in test tubes, and much less human evidence that supplementation changes tissue AGE accumulation. Compounds like carnosine and aminoguanidine have been studied in this context; aminoguanidine trials were discontinued over safety and efficacy concerns. Treat any product marketed as an anti-glycation supplement as unproven.
From Nuvirox
Why we formulated NAD+ Restore
Glycation is one of several mechanisms that make cellular maintenance harder with age. NAD+ is another — it is the coenzyme your cells depend on for energy metabolism and repair signalling, and it declines with age. We built NAD+ Restore around the precursor with the most published human trial data, at a dose that matches those trials.
- 500 mg Nicotinamide Riboside Chloride (NR) — one of the two most-researched NAD+ precursors, within the dose range used in published human trials.
- 150 mg trans-resveratrol (Japanese Knotweed) and 50 mg quercetin (Sophora japonica) — polyphenols studied alongside NAD+ pathways for cellular health support.
- 10 mg galactomannans from fenugreek — to support absorption.
- 60-day money-back guarantee — long enough to actually evaluate it the way the research says you should.
The bottom line
Glycation is legitimate biochemistry and a genuine contributor to how tissues age, particularly in the slow-turnover proteins of skin and arteries. What it is not is a solved problem with a dietary fix. The best pooled evidence shows modest improvements in insulin resistance and cholesterol from lower-AGE diets, and the best-controlled trial in healthy adults showed the biochemistry move without any physiological consequence over six weeks. If you want to reduce glycation, keeping average blood sugar in a good range and favouring moist cooking methods are reasonable, low-cost choices. Anything sold as an anti-glycation breakthrough is running well ahead of the data.
References
- Semba RD, Gebauer SK, Baer DJ, et al. Dietary intake of advanced glycation end products did not affect endothelial function and inflammation in healthy adults in a randomized controlled trial. J Nutr. 2014;144(7):1037–1042. PMID: 24744309. DOI: 10.3945/jn.113.189480. Trial: NCT01402973.
- Clarke RE, Dordevic AL, Tan SM, Ryan L, Coughlan MT. Dietary advanced glycation end products and risk factors for chronic disease: a systematic review of randomised controlled trials. Nutrients. 2016;8(3):125. DOI: 10.3390/nu8030125. PMCID: PMC4808855.
- Baye E, Kiriakova V, Uribarri J, Moran LJ, de Courten B. Consumption of diets with low advanced glycation end products improves cardiometabolic parameters: meta-analysis of randomised controlled trials. Sci Rep. 2017;7:2266. DOI: 10.1038/s41598-017-02268-0.
- Detopoulou P, Voulgaridou G, Seva V, et al. Dietary restriction of advanced glycation end-products (AGEs) in patients with diabetes: a systematic review of randomized controlled trials. Int J Mol Sci. 2024;25(21):11407. DOI: 10.3390/ijms252111407. PMCID: PMC11546279.
- Long-term dietary restriction of advanced glycation end-products (AGEs) in older adults with type 2 diabetes is feasible and efficacious — results from a pilot RCT. Nutrients. 2020. PMID: 33076217.
- Semba RD, Nicklett EJ, Ferrucci L. Does accumulation of advanced glycation end products contribute to the aging phenotype? J Gerontol A Biol Sci Med Sci. 2010;65(9):963–975.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This article is for informational purposes only and is not a substitute for professional medical advice.